Human Gene CYBA (uc002fld.2)
  Description: Homo sapiens cytochrome b-245, alpha polypeptide (CYBA), mRNA.
RefSeq Summary (NM_000101): Cytochrome b is comprised of a light chain (alpha) and a heavy chain (beta). This gene encodes the light, alpha subunit which has been proposed as a primary component of the microbicidal oxidase system of phagocytes. Mutations in this gene are associated with autosomal recessive chronic granulomatous disease (CGD), that is characterized by the failure of activated phagocytes to generate superoxide, which is important for the microbicidal activity of these cells. [provided by RefSeq, Jul 2008]. Sequence Note: This RefSeq record was created from transcript and genomic sequence data to make the sequence consistent with the reference genome assembly. The genomic coordinates used for the transcript record were based on transcript alignments.
Transcript (Including UTRs)
   Position: hg19 chr16:88,711,495-88,717,492 Size: 5,998 Total Exon Count: 5 Strand: -
Coding Region
   Position: hg19 chr16:88,712,506-88,717,421 Size: 4,916 Coding Exon Count: 5 

Page IndexSequence and LinksUniProtKB CommentsPrimersGenetic AssociationsMalaCards
CTDGene AllelesRNA-Seq ExpressionMicroarray ExpressionRNA StructureProtein Structure
Other SpeciesGO AnnotationsmRNA DescriptionsPathwaysOther NamesGeneReviews
Model InformationMethods
Data last updated at UCSC: 2013-06-14

-  Sequence and Links to Tools and Databases
 
Genomic Sequence (chr16:88,711,495-88,717,492)mRNA (may differ from genome)Protein (128 aa)
Gene SorterGenome BrowserOther Species FASTAVisiGeneGene interactionsTable Schema
AlphaFoldBioGPSEnsemblEntrez GeneExonPrimerGeneCards
GeneNetworkH-INVHGNCLynxMalacardsMGI
OMIMPubMedUniProtKBWikipediaBioGrid CRISPR DB

-  Comments and Description Text from UniProtKB
  ID: H3BR52_HUMAN
DESCRIPTION: SubName: Full=Cytochrome b-245 light chain;
CAUTION: The sequence shown here is derived from an Ensembl automatic analysis pipeline and should be considered as preliminary data.

-  Primer design for this transcript
 

Primer3Plus can design qPCR Primers that straddle exon-exon-junctions, which amplify only cDNA, not genomic DNA.
Click here to load the transcript sequence and exon structure into Primer3Plus

Exonprimer can design one pair of Sanger sequencing primers around every exon, located in non-genic sequence.
Click here to open Exonprimer with this transcript

To design primers for a non-coding sequence, zoom to a region of interest and select from the drop-down menu: View > In External Tools > Primer3


-  Genetic Association Studies of Complex Diseases and Disorders
  Genetic Association Database (archive): CYBA
CDC HuGE Published Literature: CYBA
Positive Disease Associations: atherosclerosis , atherosclerosis, coronary , cardiac death cardiovascular disease oxidative stress , cardiovascular , Cell Adhesion Molecules , cerebrovascular disease , cervical intraepithelial neoplasia grade 3 , cholesterol , coronary artery disease , coronary endothelial vasodilator function , coronary heart disease in younger individuals. , hypertension , hypertension NADPH oxidase activity , hypertension vascular aging , Insulin Resistance|Obesity , kidney failure, acute , NADPH Oxidase , oxidative stress , periodontitis , vascular NAD(P)H oxidase activity , vasodilation, flow-mediated
Related Studies:
  1. atherosclerosis
    Hayaishi-Okano, R. et al. 2003, Association of NAD(P)H Oxidase p22 phox Gene Variation With Advanced Carotid Atherosclerosis in Japanese Type 2 Diabetes, Diabetes care. 2003 Feb;26(2):458-63. [PubMed 12547880]
    These results show that the C242T mutation in the p22 phox gene is associated with progression of asymptomatic atherosclerosis in the subjects with type 2 diabetes and is also associated with insulin resistance in nondiabetic subjects.
  2. atherosclerosis, coronary
    He, M. et al. 2004, [Study on the relationship between the polymorphism of P22phox C242T, vitamin E and coronary heart disease], Wei sheng yan jiu. 2004 Jul;33(4):443-6. [PubMed 15461271]
    The polymorphism of P22phox C242T is associated with CHD in Chinese. Vitamin E is protective against CHD and there is effect on the progress of CHD in the interaction of the polymorphism of P22phox C242T and vitamin E.
  3. atherosclerosis, coronary
    Nasti, S. et al. 2006, C242T Polymorphism in CYBA gene (p22;{phox}) and risk of coronary artery disease in a population of Caucasian Italians, Dis Markers 2006 22(3) 167-73. [PubMed 16788250]
    these results support the increased risk of developing early CAD and of having rapid progression of coronary stenosis in subjects carrying the C242T nucleotide transition among the Italian population.
  4. atherosclerosis, coronary
    Fan, M. et al. 2006, The p22phox C242T gene polymorphism is associated with a reduced risk of angiographically verified coronary artery disease in a high-risk Finnish Caucasian population. The Finnish Cardiovascular Study, Am Heart J 2006 152(3) 538-42. [PubMed 16923427]
    The T allele in the C242Tpolymorphism of the p22phox gene had a protective effect against the development of CAD despite the exposure of study subjects to risk factors related to excessive NADPH-dependent superoxide production.
  5. atherosclerosis, coronary
    He, M. A. et al. 2007, Associations of polymorphism of P22(phox) C242T, plasma levels of vitamin E, and smoking with coronary heart disease in China, Am Heart J 2007 153(4) 640.e1-6. [PubMed 17383305]
    These data provide evidence that P22(phox) genotypes are significantly associated with CHD risk in a Chinese population and suggest potential interactions among smoking, P22(phox) genotypes, and vitamin E in relation to CHD risk.
  6. cardiac death cardiovascular disease oxidative stress
    Grahl, D. A. et al. 2007, Associations between the CYBA 242C/T and the MPO -463G/A Polymorphisms, Oxidative Stress and Cardiovascular Disease in Chronic Kidney Disease Patients, Blood Purif 2007 25(2) 210-218. [PubMed 17337886]
  7. cardiovascular
    Schachinger V et al. 2001, NADH/NADPH oxidase p22 phox gene polymorphism is associated with improved coronary endothelial vasodilator function., European heart journal. 2001 Jan;22(1):96-101. [PubMed 11133215]
    The C242T polymorphism of the p22 phox gene is an important independent determinant of coronary endothelial vasodilator function. These results provide the first clinical evidence for the functional significance of a polymorphism of a gene related to superoxide anion production in the vascular wall.
  8. Cell Adhesion Molecules
    , , . [PubMed 0]
  9. cerebrovascular disease
    Ishii K 2004, Genetic risk factors for ischemic cerebrovascular disease--analysis on fifteen candidate prothrombotic gene polymorphisms in the Japanese population, Rinsho byori The Japanese journal of clinical pathology. 2004 Jan;52(1):22-7. [PubMed 14968555]
    Carrying both of the two mutations might be associated with developing CVD at a younger age.
  10. cervical intraepithelial neoplasia grade 3
    Sophia S Wang , et al. The Journal of infectious diseases 2009 199(1):20-30, Common variants in immune and DNA repair genes and risk for human papillomavirus persistence and progression to cervical cancer., The Journal of infectious diseases 2009 199(1):20-30. [PubMed 19012493]
    Our results require replication but support the role of FANCA variants in cervical cancer susceptibility and of IRF3 in HPV persistence.
  11. cholesterol
    Shimokata K 2004, Association of gene polymorphisms with coronary artery disease in individuals with or without nonfamilial hypercholesterolemia., Atherosclerosis. 2004 Jan;172(1):167-73. [PubMed 14709372]
  12. coronary artery disease
    Lee, W. H. et al. 2001, Genetic factors associated with endothelial dysfunction affect the early onset of coronary artery disease in Korean males., Vascular medicine (London, England). 2001 ;6(2):103-8. [PubMed 11530961]
    The ecNOS gene a/b polymorphism and the NADH/NADPH oxidase p22 phox gene C242T polymorphism were found to be significantly associated with the development of CAD in Korean male patients less than 51 years old.
  13. coronary endothelial vasodilator function
    Schachinger, V. et al. 2001, NADH/NADPH oxidase p22 phox gene polymorphism is associated with improved coronary endothelial vasodilator function., European heart journal. 2001 Jan;22(1):96-101. [PubMed 11133215]
    The C242T polymorphism of the p22 phox gene is an important independent determinant of coronary endothelial vasodilator function. These results provide the first clinical evidence for the functional significance of a polymorphism of a gene related to superoxide anion production in the vascular wall.
  14. coronary heart disease in younger individuals.
    Gardemann A et al. 1999, The p22 phox A640G gene polymorphism but not the C242T gene variation is associated with coronary heart disease in younger individuals., Atherosclerosis. 1999 Aug;145(2):315-23. [PubMed 10488959]
    Our observations allow the assumption that the p22 phox A640G gene polymorphism is independently associated with the presence and extent of coronary artery disease.
  15. hypertension
    Kokubo, Y. et al. 2005, Association analysis between hypertension and CYBA, CLCNKB, and KCNMB1 functional polymorphisms in the Japanese population--the Suita Study., Circulation journal. 2005 Feb;69(2):138-42. [PubMed 15671602]
    The significance of the G(-930)A polymorphism of CYBA was confirmed in the present study with adequate statistical power, which strengthens the hypothesis that this polymorphism is important in the pathogenesis of hypertension and confers susceptibility.
  16. hypertension
    Moreno MU et al. 2003, Preliminary characterisation of the promoter of the human p22(phox) gene: identification of a new polymorphism associated with hypertension., FEBS letters. 2003 May;542(3-Jan):27-31. [PubMed 12729892]
  17. hypertension
    Moreno, M. U. et al. 2007, A novel CYBA variant, the -675A/T polymorphism, is associated with essential hypertension, J Hypertens 2007 25(8) 1620-1626. [PubMed 17620958]
    The -675 CYBA polymorphism may be a novel genetic marker associated with essential hypertension. Furthermore, TT subjects exhibit features of NADPH oxidase-mediated oxidative stress and asymptomatic atherosclerosis.
  18. hypertension NADPH oxidase activity
    Moreno, M. U. et al. 2006, The C242T CYBA polymorphism of NADPH oxidase is associated with essential hypertension, J Hypertens 2006 24(7) 1299-1306. [PubMed 16794479]
    The C242T CYBA polymorphism is associated with essential hypertension.
  19. hypertension vascular aging
    Kim, K. I. et al. 2007, Impact of NAD(P)H oxidase p22(phox) gene polymorphism on vascular aging in Korean centenarian and nonagenarian, Int J Cardiol 2007. [PubMed 17307262]
    These results suggest an association between the p22(phox) C242T polymorphism and vascular aging, which might be mediated by the increase of oxidative stress.
  20. Insulin Resistance|Obesity
    M C Ochoa , et al. Journal of physiology and biochemistry 2008 64(2):127-33, G allele of the -930A>G polymorphism of the CYBA gene is associated with insulin resistance in obese subjects., Journal of physiology and biochemistry 2008 64(2):127-33. [PubMed 19043982]
  21. kidney failure, acute
    Perianayagam, M. C. et al. 2006, NADPH Oxidase p22phox and Catalase Gene Variants Are Associated with Biomarkers of Oxidative Stress and Adverse Outcomes in Acute Renal Failure, J Am Soc Nephrol 2006. [PubMed 17151330]
  22. NADPH Oxidase
    Wyche, K. E. et al. 2004, C242T CYBA Polymorphism of the NADPH Oxidase Is Associated With Reduced Respiratory Burst in Human Neutrophils, Hypertension. 2004 Jun;43(6):1246-51. [PubMed 15078863]
    Because p22(phox) exists in both the neutrophil and vessel wall, vascular oxidative stress is likely diminished in individuals with this polymorphism.
  23. oxidative stress
    Park, J. Y. et al. 2005, NADPH oxidase p22phox gene variants are associated with systemic oxidative stress biomarker responses to exercise training., Journal of applied physiology (Bethesda, Md : 1985). 2005 Nov;99(5):1905-11. [PubMed 16002772]
  24. periodontitis
    Nibali, L. et al. 2006, NADPH oxidase (CYBA) and FcgammaR polymorphisms as risk factors for aggressive periodontitis, J Clin Periodontol 2006 33(8) 529-39. [PubMed 16899095]
    C242T p22phox NADPH oxidase and FcgammaR polymorphisms may predispose to AgP through a modulation of neutrophil superoxide production.
  25. vascular NAD(P)H oxidase activity
    Guzik, T. J. et al. 2000, Functional effect of the C242T polymorphism in the NAD(P)H oxidase p22phox gene on vascular superoxide production in atherosclerosis., Circulation. 2000 Oct;102(15):1744-7. [PubMed 11023926]
    Association of the CYBA 242T allele with reduced NAD(P)H oxidase activity in human blood vessels suggests that genetic variation in NAD(P)H oxidase components may play a significant role in modulating superoxide production in human atherosclerosis.
  26. vasodilation, flow-mediated
    Fan, M. et al. 2007, CYBA C242T gene polymorphism and flow-mediated vasodilation in a population of young adults, J Hypertens 2007 25(7) 1381-1387. [PubMed 17563559]
    The C242T polymorphism of the CYBA gene seems to be related to endothelial function in a population-based sample of young healthy adults. Overweight and smoking status may modify this genetic effect.

-  MalaCards Disease Associations
  MalaCards Gene Search: CYBA
Diseases sorted by gene-association score: chronic granulomatous disease, autosomal, due to deficiency of cyba* (1300), chronic granulomatous disease* (467), phagocyte bactericidal dysfunction (9), diabetic polyneuropathy (7), atherosclerosis (6), tetralogy of fallot (1)
* = Manually curated disease association

-  Comparative Toxicogenomics Database (CTD)
  The following chemicals interact with this gene           more ... click here to view the complete list

+  Common Gene Haplotype Alleles
  Press "+" in the title bar above to open this section.

-  RNA-Seq Expression Data from GTEx (53 Tissues, 570 Donors)
  Highest median expression: 187.27 RPKM in Whole Blood
Total median expression: 1115.53 RPKM



View in GTEx track of Genome Browser    View at GTEx portal     View GTEx Body Map

+  Microarray Expression Data
  Press "+" in the title bar above to open this section.

-  mRNA Secondary Structure of 3' and 5' UTRs
 
RegionFold EnergyBasesEnergy/Base
Display As
5' UTR -36.8071-0.518 Picture PostScript Text
3' UTR -426.241011-0.422 Picture PostScript Text

The RNAfold program from the Vienna RNA Package is used to perform the secondary structure predictions and folding calculations. The estimated folding energy is in kcal/mol. The more negative the energy, the more secondary structure the RNA is likely to have.

-  Protein Domain and Structure Information
  InterPro Domains: Graphical view of domain structure
IPR007732 - Cyt_b558_asu

Pfam Domains:
PF05038 - Cytochrome Cytochrome b558 alpha-subunit

ModBase Predicted Comparative 3D Structure on H3BR52
FrontTopSide
The pictures above may be empty if there is no ModBase structure for the protein. The ModBase structure frequently covers just a fragment of the protein. You may be asked to log onto ModBase the first time you click on the pictures. It is simplest after logging in to just click on the picture again to get to the specific info on that model.

-  Orthologous Genes in Other Species
  Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
MouseRatZebrafishD. melanogasterC. elegansS. cerevisiae
No orthologGenome BrowserNo orthologNo orthologNo orthologNo ortholog
Gene DetailsGene Details    
Gene SorterGene Sorter    
 RGD    
 Protein Sequence    
 Alignment    

-  Gene Ontology (GO) Annotations with Structured Vocabulary
  Molecular Function:
GO:0020037 heme binding

Cellular Component:
GO:0016020 membrane
GO:0016021 integral component of membrane


-  Descriptions from all associated GenBank mRNAs
  BC006465 - Homo sapiens cytochrome b-245, alpha polypeptide, mRNA (cDNA clone MGC:2279 IMAGE:3502788), complete cds.
M21186 - Human neutrophil cytochrome b light chain p22 phagocyte b-cytochrome mRNA, complete cds.
HH837079 - Sequence 6 from Patent EP2231168.
HI214720 - Sequence 6 from Patent EP2076526.
HV601522 - JP 2011500003-A/6: Novel siRNA Structures.
HV708913 - JP 2012506450-A/11: Methods for treating eye disorders.
HV856595 - JP 2010507387-A/6: Novel siRNAs and Methods of Use Thereof.
HW061133 - JP 2012529430-A/8: METHODS FOR TREATING CHRONIC KIDNEY DISEASE.
HW165082 - JP 2013102767-A/6: Novel siRNA's and Use Thereof.
HW675590 - JP 2014210789-A/6: Novel siRNA Structures.
HW835278 - JP 2015051004-A/6: Novel siRNA's and Use Thereof.
JA482091 - Sequence 74 from Patent WO2011072091.
JA538121 - Sequence 6 from Patent EP2371958.
JB251941 - Sequence 8 from Patent EP2440214.
JE980383 - Sequence 74 from Patent EP2862929.
LF384486 - JP 2014500723-A/191989: Polycomb-Associated Non-Coding RNAs.
LP764840 - Sequence 8 from Patent EP3276004.
MS836043 - Sequence 7 from Patent EP3112469.
AK097127 - Homo sapiens cDNA FLJ39808 fis, clone SPLEN2009081.
AK300049 - Homo sapiens cDNA FLJ57889 complete cds, highly similar to Cytochrome b-245 light chain.
BT006861 - Homo sapiens cytochrome b-245, alpha polypeptide mRNA, complete cds.
DQ893235 - Synthetic construct clone IMAGE:100005865; FLH195484.01X; RZPDo839C12152D cytochrome b-245, alpha polypeptide (CYBA) gene, encodes complete protein.
DQ896565 - Synthetic construct Homo sapiens clone IMAGE:100011025; FLH195480.01L; RZPDo839C12151D cytochrome b-245, alpha polypeptide (CYBA) gene, encodes complete protein.
AB590173 - Synthetic construct DNA, clone: pFN21AE1371, Homo sapiens CYBA gene for cytochrome b-245, alpha polypeptide, without stop codon, in Flexi system.
BC033739 - Homo sapiens cytochrome b-245, alpha polypeptide, mRNA (cDNA clone IMAGE:5179916), with apparent retained intron.
BC028224 - Homo sapiens cytochrome b-245, alpha polypeptide, mRNA (cDNA clone IMAGE:5217162), with apparent retained intron.
BC048338 - Homo sapiens mRNA similar to cytochrome b-245, alpha polypeptide (cDNA clone IMAGE:5212219).
AK309030 - Homo sapiens cDNA, FLJ99071.
BC011565 - Homo sapiens cytochrome b-245, alpha polypeptide, mRNA (cDNA clone IMAGE:4563468), with apparent retained intron.
AK125578 - Homo sapiens cDNA FLJ43590 fis, clone SMINT2001818.
KJ901368 - Synthetic construct Homo sapiens clone ccsbBroadEn_10762 CYBA gene, encodes complete protein.
LF375076 - JP 2014500723-A/182579: Polycomb-Associated Non-Coding RNAs.
MA421964 - JP 2018519830-A/7: UTRs increasing the translation efficiency of RNA molecules.
MA620063 - JP 2018138019-A/191989: Polycomb-Associated Non-Coding RNAs.
MA610653 - JP 2018138019-A/182579: Polycomb-Associated Non-Coding RNAs.

-  Biochemical and Signaling Pathways
  KEGG - Kyoto Encyclopedia of Genes and Genomes
hsa04670 - Leukocyte transendothelial migration
hsa05140 - Leishmaniasis

-  Other Names for This Gene
  Alternate Gene Symbols: AK097127, H3BR52, H3BR52_HUMAN, NM_000101, NP_000092, uc002fld.1
UCSC ID: uc002fld.2
RefSeq Accession: NM_000101
Protein: H3BR52

-  GeneReviews for This Gene
  GeneReviews article(s) related to gene CYBA:
cgd (Chronic Granulomatous Disease)

-  Gene Model Information
 
category: coding nonsense-mediated-decay: no RNA accession: AK097127.1
exon count: 5CDS single in 3' UTR: no RNA size: 3061
ORF size: 387CDS single in intron: no Alignment % ID: 99.80
txCdsPredict score: 974.00frame shift in genome: no % Coverage: 41.33
has start codon: yes stop codon in genome: no # of Alignments: 1
has end codon: yes retained intron: no # AT/AC introns 0
selenocysteine: no end bleed into intron: 1029# strange splices: 0
Click here for a detailed description of the fields of the table above.

-  Methods, Credits, and Use Restrictions
  Click here for details on how this gene model was made and data restrictions if any.